A few weeks ago, the entire world was informed of the worst Ebola outbreak in history, taking place in West Africa, specifically throughout Sierra Leone, Guinea, and Liberia. Since then, there has been widespread fear and panic regarding the spreading of the virus. Many people in the United States are terrified that the virus will spread here, since the second American infected with the disease was recently transported to a hospital in Atlanta. Amazingly, both American patients have been treated with a highly experimental drug that has significantly improved both of their conditions. Dr. Kent Brantley and Nancy Writebol are the two American missionaries that were found to have Ebola symptoms. Both Brantley and Writebol felt typical symptoms of the disease, and after a blood test confirmed their suspicions, they were diagnosed with Ebola. Both Brantley and Writebol suffered from diarrhea, vomiting, and fever. The experimental drug that they were given is called ZMapp. It was developed by a biotechnology company called Mapp Biopharmaceutical Inc., which is based in San Diego, California. The entire world is watching to see if this drug can possibly be administered to all of those infected with the disease.